# Epidemiology
- 30-35k cases per year in the US. 7k deaths
- OC: ~30% of H&N cancers.
- 20 fold increase in SE-Asia.
- M:F 3:2
- Most common sites are lip and oral tongue. 

# Risk Factors:
- Primarily: Tobacco and EtOH
- Also: poor oral hygiene, betel and areca nuts, periodontal dz, immune suppression.
- Most are HPV negative, unless near the circumvallate papillae.
- Genetic syndromes: Fanconi's anemia and dyskeratosis congenita.

# Anatomy:
![[img_ECRO_OC_anatomy.png#invert]]![[img_ECRO_OC_RMT.png#]]
## Subregions: helpful for defining primary site treatment
- Lip, alveolar ridge (gingiva), buccal mucosa, retromolar trigone (RMT), hard palate, oral tongue, FOM. #pimp
	- Lip most common (38%), buccal mucosa least common (2%). Tongue (22%).
- Soft palate is OPx (not OC) #pimp 
- RMT: over the ascending ramus of the mandible (helpful for targeting RT)
- 3 surfaces of the gingiva #pimp 
	- Alveolar ridge (teeth implant into this), lingual, and buccal
- Tongue
	- separated by circumvallate papilla #pimp 
	- dorsum, lateral, ventral #pimp
- FOM
	- anterior and lateral #pimp
- Lip
	- only the outside/vermillion border
		- big difference in treatment if inside/outside
- #todo restructure into list


## Nerves:
| innervation            | nerve                                      |
| ---------------------- | ------------------------------------------ |
| Motor to tongue        | XII                                        |
| Motor to lips          | VII                                        |
| Sensory to oral tongue | V3 (lingual branch)                        |
| Taste                  | VII (chorda tympani),  <br>IX posteriorly. |
## Borders of OC

| border            | description                                        |
| ----------------- | -------------------------------------------------- |
| Anterior border:  | Vermillion border of lip.                          |
| Posterior border: | Circumvallate papillae, hard/soft palate junction. |
| Lateral border:   | Anterior tonsillar pillar and buccal mucosa.       |

## Extrinsic muscles of the tongue:
- Palatoglossus, Hyoglossus, Styloglossus, Genioglossus.

## misc structures
- Lingual frenulum: Division of FOM anteriorly.
- Wharton's duct: drains SMN at anterior midline FOM.
## Lymphatics 
```mermaid
graph LR;

ot(Oral Tongue) --> FOM
FOM --> g(Gingiva/RMT)
```
- Oral tongue has the greatest propensity for LN spread.
- Oral cavity LN spread: 15%! Not quite pharynx yet so not very high rates.
- Thickness < 1 mm: < 15% LN spread→ no dissection.
- Thickness 2-3 mm→ dissection.
- [Ebrahimi](https://europepmc.org/article/PMC/6563806) suggests END may not be necessary for DOI ≤ 3 mm 

|                        | T1  | T2  | T3  | T4   |
| ---------------------- | --- | --- | --- | ---- |
| Oral tongue nodal mets | 14% | 30% | -   | -    |
| FOM nodal mets         | 10% | 30% | 45% | >50% |

- First echelon drainage from OC: IB (A if very anterior) #pimp 
- Parallel drainage (skip) to level IV: Byer's node (~15%) #pimp 

# Pathology:
- 95% SqCC
- Others: minor salivary gland, mucosal melanoma, lymphoma, sarcoma. BCC of the lip. 

# Workup
## History:
- non-healing ulcer, bleeding, ill-fitting denture, otalgia, trismus.

## Ddx:
- SqCC, minor salivary gland tumor, lymphoma, melanoma, sarcoma, plasmacytoma, ameloblastoma.
- Benign DDx lip: keratoacanthoma, AK, hemangiomas, fibromas, HSV, chancre. 

## Exam:
- Attn to tongue mobility (no longer affects staging), FOM, trismus.
- Visible/palpable mass with ulceration. Possible palpable cervical lymphadenopathy
- NPG

## Imaging:
- CT neck with contrast
- Consider MRI w contrast to help assess invasion/perineural spread,
- PET/CT if stage III/IV.

## SANDS-OE
- Speech/swallow, Audiology, Nutrition, Dental, Smoking cessation - Ophthalmology, Endocrine as indicated.

# Natural History:
- Oral leukoplakia is estimated to progress 1-20% in 10 years, erythroplakia 30%. 
- 
- Secondary cancers: 1.5% will have synchronous cancers, 10-40% develop secondary cancers.

| 5y | stage I | II | III | IV |
| ---- | ---- | ---- | ---- | ---- |
| OS | 80% | 65% | 50% | 40% |

# Treatment
## Surgery vs RT
- primarily based on organ preservation 
	- possible in anterior structures, difficult/impossible posteriorly
	- need to get positive margins
- see [[Iyer (CCRT vs Sx+PORT)]]

## Neck management
- Elective neck dissection
	- Indications #pimp 
		- DOI: 3mm
		- from [[D'Cruz (elective vs therapeutic ND)]]
- Ipsilateral vs bilateral ENRT
	- laterality of primary (within 1cm?)
	- DOI
	- See [[Ganly (iLND+pGlos, no RT)]]
		- contrast to UF data [Amdur](https://pubmed.ncbi.nlm.nih.gov/30234502/) which got a 0% contralateral failure
- END preferred, but ENI is safe
	- Foster: Equivalent (if CCRT)
	- Murthy: equivalent

## RT
- indications ![[HN006 (-PET, SNLBx v ELND)#AdjRT]]
- Technique
	- IMRT at minimum (protons possible, except for tongue)
	- Bolus: [Stanford] says it's okay to omit scar bolus
	- Intraoral stent: tongue blade to create separation 
	- targets:
		- CTV: 
			- resection bed:  + 1cm
			- nodal CTC: positice node + 0.5cm
		- PTV: CTV + 3mm
	- Dose:
		
 | risk | Dose  | Primary                | Nodal      |
 | ---- | ----- | ---------------------- | ---------- |
 | HR   | 66-70 | close/positive margins | ENE        |
 | IR   | 60    | adequate margins       | +LN levels |
 | SR   | 50    |                        | ENI        |

## Chemo
- indications ![[HN006 (-PET, SNLBx v ELND)#AdjCCRT]]
	- also possibly: close SM (<5mm), multiple positive LNs
- dose: #pimp 
	- 40mg qWeekly
	- 100mg q3Weeks
- consider induction chemo in inoperable patients to try to convert to operable per [[Patil (iChemo then Sx v CCRT)]]

![[ECRO_Oral-cavity.pdf]]